Due to the small sample size, the relationships observed between CD4 and CD8 levels and poorer City of Hope questionnaire total Quality of Life score, and neuropsychological performance may not extend to all manner of active treatment breast cancer patients experiencing other modes of treatment [60, 61]. The gene discussed is CD8A; the disease is breast carcinoma.